SA PRO
Free Account
Olema Pharmaceuticals, Inc.OLMANASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
7 analysts·Limited coverage
100%
Rating Distribution
Strong Buy
00%
Buy
7100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 67% higher.

Bear Case
$38.00
+48%
Consensus
$42.71
+67%
Bull Case
$48.00
+87%
Price Range7 analysts
Low
Consensus
High
$38.00
$48.00
Current Target
Current Price
$25.65
Upside to Target
$17.06

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 7, 2026Piper Sandler
Olema Oncology initiated with an Overweight at Piper Sandler
Target:$40.00
+59.7%from $25.04
Jan 7, 2026UBS
UBS Starts Olema Pharmaceuticals (OLMA) at Buy
Target:$45.00
+79.7%from $25.04
Dec 11, 2025Oppenheimer
Olema Oncology price target raised to $48 from $45 at Oppenheimer
Target:$48.00
+51.6%from $31.66
Dec 11, 2025Goldman Sachs
Olema Oncology price target raised to $38 from $26 at Goldman Sachs
Target:$38.00
+23.9%from $30.68
Dec 11, 2025H.C. Wainwright
Olema Pharmaceuticals (OLMA) PT Raised to $45 at H.C. Wainwright
Target:$45.00
+39.7%from $32.22
Dec 10, 2025Jefferies
Olema Oncology price target raised to $43 from $30 at Jefferies
Target:$43.00
+40.2%from $30.66
Nov 21, 2025Goldman Sachs
Olema Oncology price target raised to $26 from $18 at Goldman Sachs
Target:$26.00
+18.1%from $22.01
Nov 20, 2025Guggenheim
Olema Oncology price target raised to $40 from $20 at Guggenheim
Target:$40.00
+80.5%from $22.16
Nov 18, 2025H.C. Wainwright
Olema Oncology price target raised to $36 from $28 at H.C. Wainwright
Target:$36.00
+78.7%from $20.14
Oct 20, 2025H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)
Target:$28.00
+199.1%from $9.36
Oct 8, 2025Guggenheim
Olema Oncology initiated with a Buy at Guggenheim
Target:$20.00
+91.6%from $10.44
Oct 24, 2024Goldman Sachs
Goldman Sachs Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)
Target:$27.00
+126.7%from $11.91
May 16, 2024H.C. Wainwright
Olema Pharmaceuticals (OLMA) PT Raised to $30 at H.C. Wainwright
Target:$30.00
+204.6%from $9.85
Apr 2, 2024Goldman Sachs
Goldman Sachs Starts Olema Pharmaceuticals (OLMA ) at Buy, 'Best-in-Class Potential in Large BC Market'
Target:$24.00
+120.4%from $10.89

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance